Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 33305 [2011-14200]

Download as PDF Federal Register / Vol. 76, No. 110 / Wednesday, June 8, 2011 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID) (U01), Funding Opportunity Announcement (FOA) EH11–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: sroberts on DSK5SPTVN1PROD with NOTICES Time and Date: 8 a.m.—5 p.m., July 11, 2011 (Closed). Place: Intercontinental Hotel Buckhead, 3315 Peachtree Road, NE., Atlanta, Georgia 30326, Telephone: (404) 946–9000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of SCID (U01), FOA EH11–001, initial review.’’ Contact Person for More Information: J. Felix Rogers, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488–4334. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: May 27, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–14200 Filed 6–7–11; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 21:51 Jun 07, 2011 Jkt 223001 [Document Identifier: CMS–10379] Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB); Correction Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Correction of notice. AGENCY: This document corrects the information provided for [Document Identifier: CMS–10379] titled ‘‘Rate Increase Disclosure and Review Reporting Requirements (45 CFR Part 154)’’ that was published in the Federal Register on June 1, 2011 (76 FR 31613). FOR FURTHER INFORMATION CONTACT: William N. Parham, III, (410) 786– 4669. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background In FR Doc. 2011–13458 of June 1, 2011 (76 FR 31316), we published a Paperwork Reduction Act notice requesting a 30-day public comment period for the information collection request titled ‘‘Rate Increase Disclosure and Review Reporting Requirements (45 CFR Part 154).’’ However, there was a technical error that is identified and corrected in the Correction of Errors section below. The information in this correction notice is effective as if it had been included in the document published June 1, 2011. Accordingly, the information collection requirements are not effective until approved by OMB. II. Explanation of Error In FR Doc. 2011–13458 of June 1, 2011 (76 FR 31316), information provided under column 3, between paragraphs 1 and 2, on page 69218, was inadvertently omitted. This notice corrects the omission by adding the appropriate instructions and contact information for individuals seeking copies of the proposed information collection. III. Correction of Error In FR Doc. 2011–13458 of June 1, 2011 (76 FR 31613), page 31614, in the third column, in between the first and second paragraphs, the language is corrected to read as follows: To obtain copies of the supporting statement and any related forms for the PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 33305 proposed paperwork collections referenced above, access CMS Web Site address at https://www.cms.gov/ PaperworkReductionActof1995/PRAL/ list.asp or E-mail your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786–1326. Dated: June 6, 2011. Martique Jones, Director, Regulations Development Group, Division B, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2011–14306 Filed 6–6–11; 4:15 pm] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–5502–CN] Medicare Program; Accelerated Development Sessions for Accountable Care Organizations— June 20, 21, and 22, 2011; Corrections Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Correction notice. AGENCY: This document corrects technical errors that appeared in the notice published in the May 19, 2011 Federal Register entitled ‘‘Medicare Program; Accelerated Development Sessions for Accountable Care Organizations—June 20, 21, and 22, 2011.’’ SUMMARY: FOR FURTHER INFORMATION CONTACT: Erica Tibbals, (410) 786–6457. SUPPLEMENTARY INFORMATION: I. Background In FR Doc. 2011–12342 of May 19, 2011 (76 FR 28988), there were a number of technical errors that are identified and corrected in the Correction of Errors section. II. Summary of Errors We made technical and typographical errors in the May 19, 2011 notice (76 FR 28988 and 28989) which include the following: • Incorrectly referenced the learning sessions as accelerated development sessions (ADSs) instead of accelerated development learning sessions (ADLSs). • Made inadvertent errors in our description of the persons who are invited to participate in the in-person session. E:\FR\FM\08JNN1.SGM 08JNN1

Agencies

[Federal Register Volume 76, Number 110 (Wednesday, June 8, 2011)]
[Notices]
[Page 33305]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14200]



[[Page 33305]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Program to Support New 
Implementation of State or Territorial Public Health Laboratory 
Capacity for Newborn Bloodspot Screening of Severe Combined Immune 
Deficiency (SCID) (U01), Funding Opportunity Announcement (FOA) EH11-
001, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8 a.m.--5 p.m., July 11, 2011 (Closed).
    Place: Intercontinental Hotel Buckhead, 3315 Peachtree Road, 
NE., Atlanta, Georgia 30326, Telephone: (404) 946-9000.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Program to Support New Implementation of State or 
Territorial Public Health Laboratory Capacity for Newborn Bloodspot 
Screening of SCID (U01), FOA EH11-001, initial review.''
    Contact Person for More Information: J. Felix Rogers, Ph.D., 
M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway, 
Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488-4334.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: May 27, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-14200 Filed 6-7-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.